Clinical Trial Update: Study of Vintafolide (MK-8109, EC145) in Participants With Advanced Ovarian and Endometrial Cancers (MK-8109-007, EC-FV-02) [Phase 2]

View source ↗

Summary

A Phase 2 study of vintafolide (MK-8109, EC145) in advanced ovarian and endometrial cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer
• Ovarian Cancer

Drugs mentioned

• Vintafolide (MK-8109 / EC145)

Snippet

Sponsor: Endocyte | Conditions: Ovarian Cancer, Endometrial Cancer | Phase 2 | Status: COMPLETED